Latest Innovation News

Fisher & Paykel Healthcare has reported a record full-year revenue of NZ$2.02 billion for FY2025, alongside a 43% increase in underlying net profit after tax. The company also raised its dividend, reflecting strong operational performance and strategic investments.

Infratil Limited reported a robust FY2025 with operational EBITDAF nearing NZ$1 billion, driven by strong performances across its core infrastructure sectors and a strategic capital raise to fuel CDC Data Centres’ expansion.

Smartpay has reported an 8.5% rise in consolidated revenue for FY2025, driven by growth in Australia and a bold entry into New Zealand’s acquiring market. However, investments in technology and market expansion have weighed on EBITDA.

Smartpay Holdings Limited posted solid FY25 financials with revenue surpassing $104 million, driven by Australian market gains and promising New Zealand pilot progress. The company is advancing its trans-Tasman payments strategy amid regulatory developments.

4DMedical has submitted its CT:VQ lung imaging technology for FDA clearance, aiming to disrupt the $1 billion US nuclear lung scan market with a non-nuclear, lower-cost alternative. Clinical studies show CT:VQ matches or exceeds existing nuclear imaging in accuracy and patient experience.

Assetora Limited has launched the Australian Homeowner Equity Fund, a $100 million initiative offering shared equity investments with a targeted 12% annual return, following a successful pilot with AMP Bank.

Viridis Mining and Minerals, through its joint venture Viridion, has delivered the first batch of high-purity rare earth oxides recycled from Brazilian magnets to Latin America’s only magnet manufacturer, marking a key step in establishing a domestic rare earth supply chain.

Ionic Rare Earths, through its Viridion joint venture, has delivered the first recycled rare earth oxides to Brazil’s CIT SENAI ITR, marking a key step toward a domestic magnet supply chain in South America.

Prescient Therapeutics has reached a pivotal milestone by dosing the first patient in its Phase 2a clinical trial of PTX-100 for relapsed/refractory Cutaneous T-Cell Lymphoma (CTCL), aiming to evaluate safety and efficacy across multiple international sites.

Talius has deepened its partnership with Silverchain Group to pilot an AI voice assistant aimed at transforming home aged care services, starting with appointment scheduling in Western Australia and eyeing a national rollout.

InFocus Group Holdings has secured a $3.25 million contract to develop a cutting-edge white-label iGaming platform for Taiwanese firm TG Solutions, marking a significant expansion into the digital gaming sector.

Optiscan Imaging Ltd has reached a pivotal milestone with the completion of its cloud-based telepathology software MVP, enabling secure, real-time remote collaboration for digital pathology.